Iron Metabolism and Inflammatory Mediators in Patients with Renal DysfunctionTomomi Matsuoka, Hiroki Kobayashi, Masanori Abe|International Journal of Molecular Sciences|2024Cited by 32
Association of Oral Frailty with Physical Frailty and Malnutrition in Patients on Peritoneal DialysisYu Kobayashi, Masanori Abe, Tomomi Matsuoka et al.|Nutrients|2025Cited by 5
3P-0836 Biological characterization of ER129614-06, a novel, non-peptide protease-activated receptor-1 (PAR-1) antagonistMotoji Kogushi, Ieharu Hishinuma, Tomomi Matsuoka et al.|Atherosclerosis Supplements|2003Cited by 4
The prognostic value of serum hepcidin-25 in predicting cardiovascular events among maintenance hemodialysis patients: insights from the INFINITY cohortTomomi Matsuoka, Hiroki Kobayashi, Hyoe Tomita et al.|Clinical and Experimental Nephrology|2025Cited by 3
Limited Utility of Serum Hepcidin as a Marker for Erythropoiesis‐Stimulating Agent Hyporesponsiveness in Hemodialysis Patients: An Analysis From the <scp>INFINITY</scp> CohortTomomi Matsuoka, Hiroki Kobayashi, Hyoe Tomita et al.|Therapeutic Apheresis and Dialysis|2025Cited by 1